CORRECTION: Medirom Healthcare Technologies FY23 Revenue $48.45M
$MRM
Other Consumer Services
Consumer Discretionary
CORRECTION: Medirom Healthcare Technologies FY23 Revenue $48.45M
Save time and jump to the most important pieces.
TOKYO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) announced a business alliance with SBC Medical Group Holdings Incorporated (NASDAQ:SBC) a global owner, operator and provider of management services and products to cosmetic treatment centers. Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC's "Shonan Beauty Clinic" and MEDIROM's "Re.Ra.Ku wellness salon". In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SB
Leveraging the strengths of each partner to create synergies and expand the customer base SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical", or the "Company", or "SBC"), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced a business alliance with MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM"), a rapidly growing company in the healthcare technology field with over 300 relaxation studios in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241103701498/en/SBC Medical Group Holdings Incorporated, a global owner, operator and pr
TOKYO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lead Real Estate Co., LTD (NASDAQ:LRE), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, and which develops and operates the ENT TERRACE brand of extended-stay hotels, today announced that LRE will introduce MOTHER Bracelet ®︎, a fitness tracker developed by MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM), which operates a health tech business, to two hotels under the ENT TERRACE brand. This initiative will launch on Friday, November 1st, under the theme "Circulation of Happiness through Energy o
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
F-1/A - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor
MEDIROM Healthcare Technologies Inc. ("we", "our", "us" or "the Company") hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase a rehabilitation business from Y's, Inc., a Japanese corporation, as of July 10, 2024. Y`s, Inc. operates 10 rehabilitation facilities around Tokyo for survivors of cerebral infarction, a type of stroke, and the company does business with major private, public and university hospitals in Japan. Y's, Inc. started its Cerebral Infarction Rehabilitation Center business with an awareness that people suffering from the aftereffects of cerebral infarction are not receiving adequate rehabilitation. The goal is to create a s